Institutional investors purchased a net $610.2 thousand shares of AMRI during the quarter ended June 2015. This may signal that the smart money is gaining interest in this company as the 102.35% of shares outstanding that institutional investors hold is actually below the Services to the Health Industry industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VISIUM ASSET MANAGEMENT LP Bought 1.8 Million shares of Albany Molecular Research...
PALISADE CAPITAL MANAGEMENT LLC Bought 230.2 Thousand shares of Albany Molecular Research...